Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug:129:104500.
doi: 10.1016/j.jcv.2020.104500. Epub 2020 Jun 8.

Evaluation of rapid antigen test for detection of SARS-CoV-2 virus

Affiliations

Evaluation of rapid antigen test for detection of SARS-CoV-2 virus

Gannon Ck Mak et al. J Clin Virol. 2020 Aug.

Abstract

Background: The rapid diagnosis of Coronavirus Disease 2019 (COVID-19) patients is essential to reduce the disease spread. Rapid antigen detection (RAD) tests are available, however, there is scanty data on the performance of RAD tests.

Objective: To evaluate the performance of the commercially available BIOCREDIT COVID-19 Ag test and compare it with RT-PCR for detecting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus. Analytical sensitivity for the detection of SARS-CoV-2 virus was determined for the RAD test using viral culture and RT-PCR as reference methods. The RAD test was further evaluated using respiratory samples collected from confirmed COVID-19 patients. The results were compared with RT-PCR test.

Results: The detection limits between RAD test, viral culture and RT-PCR varied hugely. RAD was 103 fold less sensitive than viral culture while RAD was 105 fold less sensitive than RT-PCR. The RAD test detected between 11.1 % and 45.7 % of RT-PCR-positive samples from COVID-19 patients.

Conclusions: This study demonstrated that the RAD test serves only as adjunct to RT-PCR test because of potential for false-negative results.

Keywords: 2019 novel coronavirus; COVID-19; RT-PCR; Rapid antigen detection; SARS-CoV-2; Viral culture.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest None.

Figures

Fig. 1
Fig. 1
The results of the 160 respiratory samples tested for rapid antigen detection test and the corresponding Ct values of SARS-CoV-2 virus–specific RT-PCR.

References

    1. WHO . 2020. Coronavirus Disease (COVID-2019) Situation Report – 51.https://www.who.int/docs/default-source/coronaviruse/situation-reports/2... 11 March.Available from:
    1. WHO . 2020. Laboratory Testing for Coronavirus Disease 2019 (COVID-19) in Suspected Human Cases: Interim Guidance, 2 March.https://apps.who.int/iris/handle/10665/331329 Available from:
    1. WHO . 2020. Laboratory Testing Strategy Recommendations for COVID-19: Interim Guidance.https://apps.who.int/iris/handle/10665/331509 21 March. Available from:
    1. WHO . 2020. WHO Reference Laboratories Providing Confirmatory Testing for COVID-19.https://www.who.int/who-documents-detail/who-reference-laboratories-prov... (last updated: 29 April 2020). Available from:
    1. Scohy A., Anantharajah A., Bodéus M., Kabamba-Mukadi B., Verroken A., Rodriguez-Villalobos H. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. J. Clin. Virol. 2020;(May):21. 2020 published online ahead of print. - PMC - PubMed

Publication types

Substances